In June 2021, the Food & Drug Administration authorised Wegovy (generic identify: Semaglutide) for continual weight administration—making it the simplest treatment of its form to hit the market in many years. Administered utilizing a easy pen that injects the treatment beneath the pores and skin, Wegovy mimics the hormone generally known as glucagon-like peptide-1 (GLP-1), which is a substance that impacts the areas of the mind that assist regulate meals consumption and urge for food.
Since its approval, nevertheless, getting Wegovy into the fingers of sufferers has been extraordinarily tough each right here at True You Weight Loss and throughout the nation. This is because of a mix of things together with manufacturing points and an extremely excessive demand for the treatment.
“In our follow alone, now we have tons of of sufferers ready to begin taking Wegovy,” explains Dr. Christopher McGowan, Founder and Medical Director of True You Weight Loss. “Many different sufferers have needed to both cease taking the treatment, swap doses, or transfer to interim therapies amidst the scarcity. This treatment is an especially efficient device within the battle towards weight problems. In consequence, the shortages have had an actual and lasting influence on our sufferers, so we’re very desperate to see a decision within the coming months.”
Is the Wegovy Scarcity Lastly Ending?
Luckily, as of immediately (December 28, 2022) Wegovy producer Novo Nordisk has confirmed that each one dose strengths of Wegovy at the moment are out there to retail pharmacies nationwide—giving many sufferers hope of lastly having access to the treatment in 2023. The producer warned that pharmacies could expertise regular delays “given the time required to order the product from their native distribution middle, and geographical variabilities.”
“Based mostly on current communication with our Novo Nordisk gross sales consultant as of simply this month, now we have each purpose to hope that we’ll be capable of resume our complete True You Rx program for sufferers who’re eligible for Wegovy in early 2023,” explains Dr. McGowan.
It’s necessary to notice that Wegovy is meant to be taken indefinitely, much like different medicines for continual well being situations corresponding to excessive ldl cholesterol or diabetes. Dr. McGowan and his staff remind sufferers that in scientific trials, sufferers who stopped taking Wegovy usually regained most or all the weight that had been misplaced.
“As weight problems drugs physicians, accessing these efficient medicines is extremely necessary in serving to our sufferers enhance their well being and high quality of life. I’m thrilled to see the medical group lastly begin acknowledging weight problems as a continual illness, reasonably than an issue of alternative or willpower.”
Whereas it’s tough to know when the treatment will turn into broadly out there at retail pharmacies, we’re hopeful that we will start prescribing Wegovy once more by January 2023 for eligible sufferers.
Wegovy is similar treatment as a beforehand authorised antidiabetic drug known as Ozempic. Nevertheless, Wegovy is indicated and prescribed particularly for weight administration. However, solely sufferers with diabetes can or can be prescribed Ozempic. Each medicine have a number of key capabilities:
- improves the secretion of insulin by the pancreas
- encourages smaller meal dimension and extends a sense of fullness because of the abdomen emptying extra slowly
- reduces blood sugar by limiting glucose manufacturing within the liver
- slows down intestinal motility
- reduces starvation by results on the urge for food facilities within the mind
Due to the potential for gastrointestinal unintended effects, the dose is elevated progressively over a interval of 16 to twenty weeks to a full dose of two.4 mg as soon as per week. Wegovy isn’t meant to be mixed with different weight reduction medicines or different merchandise that include semaglutide.
Who’s Eligible for Wegovy?
Wegovy is meant for overweight or obese sufferers who’ve a BMI of 30 or greater—or a BMI of 27 or greater with a further obesity-related well being drawback (corresponding to kind 2 diabetes, hypertension, or excessive ldl cholesterol).
Frequent Aspect Results of Wegovy
The extended dosage enhance and the usage of subcutaneous injection are aimed toward serving to the physique slowly alter to the treatment, however there are some doable unintended effects. The influence on bowel motility specifically can have hostile results on the gastrointestinal tract; nausea, vomiting, stomach ache, diarrhea, constipation, or indigestion are a few of the extra frequent unintended effects. Folks with kind 2 diabetes could even expertise hypoglycemia (low blood sugar) because of the drug’s impact on insulin manufacturing.
How A lot Weight Do Sufferers Lose on Wegovy?
In one of the vital profitable trials, members had a median preliminary physique weight of 231 kilos and a BMI of 38. Individuals who obtained Wegovy misplaced a median of 14.9% of their preliminary physique weight (a lack of about 33 kilos) through the 68-week trial. Those that obtained a placebo misplaced solely 2.4% of their physique weight. Because of its influence on each weight reduction and blood sugar management, Wegovy can also be nonetheless particularly efficient for individuals with kind 2 diabetes.
About True You Rx
True You Weight Loss recommends reducing weight with Wegovy as a part of a complete weight administration program to incorporate a bodily health routine, dietary help, and wholesome consuming habits. Our True You Rx program begins with an preliminary treatment session to evaluation your medical historical past, talk about your weight reduction objectives, and decide if Wegovy is an applicable therapy for you, together with an preliminary diet session. If authorised, you’ll meet with a well being coach on a month-to-month foundation, and can obtain ongoing treatment help out of your doctor. Your Wegovy prescription can be refilled on a month-to-month foundation at your native pharmacy.